Back to Agenda
CDER Town Hall (Part 2 of 2)
Session Chair(s)
Nancy D. Smith, PHD
Adjunct Professor, Temple University, FDA Alumni, United States
This forum is a roundtable discussion with CDER leadership. It will include discussion and updates on regulatory changes; hot topics at CDER will be discussed, and the audience will be invited to submit questions of general interest.
Part 2 will take place on Thursday at 9:00 am (Session #414).
Please come prepared with your questions for the CDER Town Hall panel. You may submit questions and topics of interest in advance to annualmeetingprogram@diahome.org, and include “CDER Town Hall” in the subject line.
Learning Objective : Summarize key issues discussed by CDER; Identify regulatory hot topics.
Speaker(s)
Gerald Dal Pan, MD, MHS
Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Panelist
John Jenkins
Principal, JKJ Advisors, LLC, United States
Panelist
Sandra Kweder, MD
Principal, Drug and Biological Products , Eliquent Life Sciences, United States
Panelist
Justina Molzon, JD, MS
Consumer Services, Consumer Services, United States
Panelist
Christine Moore, PHD
Executive Director, Global External Advocacy and Standards, Organon & Co., United States
Panelist
Have an account?